+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Swine Vaccines Market Size, Share & Trends Analysis Report by Product (Recombinant, Inactivated), by Type (Pseudorabies, Porcine Circovirus Type 2), by Region (Asia Pacific, North America), and Segment Forecasts, 2021-2028

  • ID: 5526499
  • Report
  • January 2022
  • Region: Global
  • 150 Pages
  • Grand View Research

FEATURED COMPANIES

  • Biogenesis Bagó
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Elanco
  • HIPRA
  • KM Biologics
The global swine vaccines market size is expected to reach USD 2.09 billion by 2028, registering a CAGR of 4.9% over the forecast period. Increasing prevalence of diseases, a surge in the demand for animal protein, and growth in R&D expenditure for vaccines innovation are driving the market growth. Porcine Parvovirus (PPV), Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine circovirus type 2 (PCV2), Foot & Mouth Disease, Classical Swine Fever, and others remain to be extremely prevalent diseases in pig farms affecting economic losses.



The COVID-19 pandemic directly or indirectly impacted the business, results of operations, and financial conditions of market players. The Animal Health business was confronted with various production and supply bottlenecks because of the COVID-19 pandemic; this consists of delays in the delivery of raw materials and active ingredients and capacity constraints in freight transport (especially air and sea freight). While on the other side, the industry has expanded its research at an unprecedented pace in animal health. Thereby, the COVID-19 pandemic significantly impacted the market growth.

In addition, the growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth. For instance, in May 2020, Indian Immunologicals Ltd. introduced the Classical Swine Fever vaccine. Stating that it has introduced the product under the brand name ‘Raksha Class’. This is a unique cell culture technology-based vaccine developed in cooperation with the Indian Veterinary Research Institute, Bareilly.

Key players are involved in strategic initiatives, such as joint ventures, mergers, acquisitions, and new product launches to gain a higher market share. For instance, in February 2020, the new vaccine created by ICAR, Indian Veterinary Research Institute (IVRI), based in Uttar Pradesh, was much cheaper than an already existing one. It costs only Rs 2 for each dose over the present vaccine’s rate of Rs 15-20 for each dose and an imported Korean vaccine rate of Rs 30 for each dose.

Swine Vaccines Market Report Highlights

  • The inactivated vaccines segment dominated the market in 2020 owing to its easy availability and low cost over others
  • A recombinant vaccine is expected to register the fastest CAGR over the forecast period owing to the benefits, such as enhanced effectiveness, technology advancement, and increased long-standing prevention
  • The Porcine circovirus type 2 segment dominated the market in 2020 due to the increased prevalence of the disease. Moreover, this is the quickly mutating of all single-stranded DNA (ssDNA) viruses, therefore it has a great mutation and recombination rate
  • Asia Pacific is expected to register the fastest CAGR over the forecast period due to the growing cases of infectious diseases in swine, increasing awareness about animal health, rising demand for animal protein, and rapid urbanization


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Swine Vaccines Market

What is the estimated value of the Global Swine Vaccines Market?

The Global Swine Vaccines Market was estimated to be valued at $1.5 Billion in 2021.

What is the growth rate of the Global Swine Vaccines Market?

The growth rate of the Global Swine Vaccines Market is 4.9%, with an estimated value of $2.1 Billion by 2028.

What is the forecasted size of the Global Swine Vaccines Market?

The Global Swine Vaccines Market is estimated to be worth $2.1 Billion by 2028.

Who are the key companies in the Global Swine Vaccines Market?

Key companies in the Global Swine Vaccines Market include Merck Animal Health, Ceva Sante Animale, Zoetis, Boehringer Ingelheim GmbH, Elanco, Indian Immunologicals Ltd., Biogenesis Bagó, Phibro Animal Health and HIPRA.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biogenesis Bagó
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Elanco
  • HIPRA
  • KM Biologics

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Summary, 2020
Chapter 3. Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Swine Vaccines Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Swine Vaccines Industry Analysis-Porter’s
3.4.1. Supplier Power
3.4.2. Buyer Power
3.4.3. Substitution Threat
3.4.4. Threat of New Entrants
3.4.5. Competitive Rivalry
3.5. Swine Vaccines Industry Analysis-PEST
3.5.1. Political & Legal Landscape
3.5.2. Economic Landscape
3.5.3. Social Landscape
3.5.4. Technology Landscape
3.6. Regulatory Framework
Chapter 4. Impact of COVID-19 on Swine Vaccines Market
4.1. Disease Prevalence Analysis
4.2. Covid-19 Impact and Future Scenario
4.3. Strategies Implemented by Companies
4.4. Impact on Market Players
Chapter 5. Swine Vaccines Market : Type Estimates & Trend Analysis
5.1. Type Movement Analysis & Market Share, 2020 & 2028
5.2. Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the following:
5.2.1. Swine Influenza
5.2.2. Classical Swine Fever
5.2.3. Porcine Parvovirus
5.2.4. Porcine Circovirus Type 2
5.2.5. M.Hyo
5.2.6. Actinobacillus Pleuropneumonia
5.2.7. PRRS
5.2.8. Foot & Mouth Disease
5.2.9. Pseudorabies
5.2.10. PEDV
5.2.11. Others
Chapter 6. Swine Vaccines Market : Product Estimates & Trend Analysis
6.1. Product Movement Analysis & Market Share, 2020 & 2028
6.2. Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the following:
6.2.1 Attenuated Live Vaccines
6.2.2 Inactivated Vaccines
6.2.3 Subunit Vaccines
6.2.4 DNA Vaccines
6.2.5 Recombinant Vaccines
Chapter 7. Swine Vaccines Market : Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2020 & 2028
7.2. Market Share Analysis, by Region
7.3. Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the following:
7.3.1. North America
7.3.1.1. U.S.
7.3.1.2. Canada
7.3.2. Europe
7.3.2.1. U.K.
7.3.2.2. Germany
7.3.2.3. France
7.3.2.4. Italy
7.3.2.5. Spain
7.3.3. Asia Pacific
7.3.3.1. Japan
7.3.3.2. China
7.3.3.3. India
7.3.4. Latin America
7.3.4.1. Brazil
7.3.4.2. Mexico
7.3.4.3 Argentina
7.3.5. Middle East & Africa
7.3.5.1. South Africa
7.3.5.2 Saudi Arabia
Chapter 8. Competitive Landscape
8.1. Market Participation Categorization
8.2. Public Companies
8.2.1. Company Market Share/Position Analysis
8.2.2. Heat Map Analysis
8.3. Private Companies
8.3.1. List of Key Companies
Chapter 9. Company Profiles
9.1. Company Profiles
9.1.1. Merck Animal Health
9.1.1.1. Company Overview
9.1.1.2. Financial Performance
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. Ceva Sante Animale
9.1.2.1. Company Overview
9.1.2.2. Financial Performance
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Zoetis
9.1.3.1. Company Overview
9.1.3.2. Financial Performance
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Boehringer Ingelheim GmbH
9.1.4.1. Company Overview
9.1.4.2. Financial Performance
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. Elanco
9.1.5.1. Company Overview
9.1.5.2. Financial Performance
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. Indian Immunologicals Ltd.
9.1.6.1. Company Overview
9.1.6.2. Financial Performance
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. Biogenesis Bagó
9.1.7.1. Company Overview
9.1.7.2. Financial Performance
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. Phibro Animal Health
9.1.8.1. Company Overview
9.1.8.2. Financial Performance
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
9.1.9. KM Biologics
9.1.9.1. Company Overview
9.1.9.2. Financial Performance
9.1.9.3. Product Benchmarking
9.1.9.4. Strategic Initiatives
9.1.10. HIPRA
9.1.10.1. Company Overview
9.1.10.2. Financial Performance
9.1.10.3. Product Benchmarking
9.1.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 North America Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 3 North America Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 4 The U.S. Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 5 The U.S. Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 6 Canada Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 7 Canada Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 8 Europe Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 9 Europe Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 10 U.K. Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 11 U.K. Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 12 Germany Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 13 Germany Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 14 France Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 15 France Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 16 Italy Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 17 Italy Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 18 Spain Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 19 Spain Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 20 Asia Pacific Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 21 Asia Pacific Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 22 Japan Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 23 Japan Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 24 China Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 25 China Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 26 India Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 27 India Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 28 Latin America Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 29 Latin America Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 30 Brazil Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 31 Brazil Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 32 Mexico Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 33 Mexico Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 34 Argentina Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 35 Argentina Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 36 MEA Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 37 MEA Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 38 South Africa Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 39 South Africa Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
Table 40 Saudi Arabia Swine Vaccines market revenues, by type, 2016-2028 (Revenue, USD Million)
Table 41 Saudi Arabia Swine Vaccines market revenues, by product, 2016-2028 (Revenue, USD Million)
List of Charts
Fig. 1 Swine Vaccines Segmentation and Scope
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Market snapshot, 2020 (USD Million)
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Swine Vaccines market: Type movement analysis
Fig. 13 Swine Vaccines market type outlook: Key takeaways
Fig. 14 Swine Influenza
Fig. 15 Classical Swine Fever
Fig. 16 Porcine Parvovirus
Fig. 17 Porcine Circovirus Type 2
Fig. 18 M.Hyo
Fig. 19 Actinobacillus Pleuropneumonia
Fig. 20 PRRS
Fig. 21 Foot & Mouth Disease
Fig. 22 Pseudorabies
Fig. 23 PEDV
Fig. 24 Others, 2016-2028 (USD Million)
Fig. 25 Swine Vaccines market: Product movement analysis
Fig. 26 Swine Vaccines market product outlook: Key takeaways
Fig. 27 Attenuated Live Vaccines
Fig. 28 Inactivated Vaccines
Fig. 29 Subunit Vaccines
Fig. 30 DNA Vaccines
Fig. 31 Recombinant Vaccines, 2016-2028 (USD Million)
Fig. 32 Swine Vaccines market: Regional movement analysis
Fig. 33 Regional marketplace: Key takeaways
Fig. 34 North America Swine Vaccines market, by country, 2016-2028 (USD Million)
Fig. 35 The U.S. Swine Vaccines market, 2016-2028 (USD Million)
Fig. 36 Canada Swine Vaccines market, 2016-2028 (USD Million)
Fig. 37 Europe Swine Vaccines market, by country, 2016-2028 (USD Million)
Fig. 38 U.K. Swine Vaccines market, 2016-2028 (USD Million)
Fig. 39 Germany Swine Vaccines market, 2016-2028 (USD Million)
Fig. 40 France Swine Vaccines market, 2016-2028 (USD Million)
Fig. 41 Italy Swine Vaccines market, 2016-2028 (USD Million)
Fig. 42 Spain Swine Vaccines market, 2016-2028 (USD Million)
Fig. 43 Asia Pacific Swine Vaccines market, by country, 2016-2028 (USD Million)
Fig. 44 Japan implantation Swine Vaccines market, 2016-2028 (USD Million)
Fig. 45 China Swine Vaccines market, 2016-2028 (USD Million)
Fig. 46 India Swine Vaccines market, 2016-2028 (USD Million)
Fig. 47 Latin America Swine Vaccines market, by country, 2016-2028 (USD Million)
Fig. 48 Brazil Swine Vaccines market, 2016-2028 (USD Million)
Fig. 49 Mexico Swine Vaccines market, 2016-2028 (USD Million)
Fig. 49 Argentina Swine Vaccines market, 2016-2028 (USD Million)
Fig. 50 MEA Swine Vaccines market, by country, 2016-2028 (USD Million)
Fig. 51 South Africa Swine Vaccines market, 2016-2028 (USD Million)
Fig. 52 Saudi Arabia Swine Vaccines market, 2016-2028 (USD Million)
Note: Product cover images may vary from those shown
  • Merck Animal Health
  • Ceva Sante Animale
  • Zoetis
  • Boehringer Ingelheim GmbH
  • Elanco
  • Indian Immunologicals Ltd.
  • Biogenesis Bagó
  • Phibro Animal Health
  • KM Biologics
  • HIPRA
Note: Product cover images may vary from those shown

Loading
LOADING...